191 related articles for article (PubMed ID: 19329795)
41. Assembly of functional ALT-associated promyelocytic leukemia bodies requires Nijmegen Breakage Syndrome 1.
Wu G; Jiang X; Lee WH; Chen PL
Cancer Res; 2003 May; 63(10):2589-95. PubMed ID: 12750284
[TBL] [Abstract][Full Text] [Related]
42. On BLM helicase in recombination-mediated telomere maintenance.
Rezazadeh S
Mol Biol Rep; 2013 Apr; 40(4):3049-64. PubMed ID: 23268311
[TBL] [Abstract][Full Text] [Related]
43. FANCM, BRCA1, and BLM cooperatively resolve the replication stress at the ALT telomeres.
Pan X; Drosopoulos WC; Sethi L; Madireddy A; Schildkraut CL; Zhang D
Proc Natl Acad Sci U S A; 2017 Jul; 114(29):E5940-E5949. PubMed ID: 28673972
[TBL] [Abstract][Full Text] [Related]
44. POT1 stimulates RecQ helicases WRN and BLM to unwind telomeric DNA substrates.
Opresko PL; Mason PA; Podell ER; Lei M; Hickson ID; Cech TR; Bohr VA
J Biol Chem; 2005 Sep; 280(37):32069-80. PubMed ID: 16030011
[TBL] [Abstract][Full Text] [Related]
45. Telosome, a mammalian telomere-associated complex formed by multiple telomeric proteins.
Liu D; O'Connor MS; Qin J; Songyang Z
J Biol Chem; 2004 Dec; 279(49):51338-42. PubMed ID: 15383534
[TBL] [Abstract][Full Text] [Related]
46. Rif1 provides a new DNA-binding interface for the Bloom syndrome complex to maintain normal replication.
Xu D; Muniandy P; Leo E; Yin J; Thangavel S; Shen X; Ii M; Agama K; Guo R; Fox D; Meetei AR; Wilson L; Nguyen H; Weng NP; Brill SJ; Li L; Vindigni A; Pommier Y; Seidman M; Wang W
EMBO J; 2010 Sep; 29(18):3140-55. PubMed ID: 20711169
[TBL] [Abstract][Full Text] [Related]
47. ALT-associated PML bodies are present in viable cells and are enriched in cells in the G(2)/M phase of the cell cycle.
Grobelny JV; Godwin AK; Broccoli D
J Cell Sci; 2000 Dec; 113 Pt 24():4577-85. PubMed ID: 11082050
[TBL] [Abstract][Full Text] [Related]
48. Depletion of Ku70/80 reduces the levels of extrachromosomal telomeric circles and inhibits proliferation of ALT cells.
Li B; Reddy S; Comai L
Aging (Albany NY); 2011 Apr; 3(4):395-406. PubMed ID: 21512205
[TBL] [Abstract][Full Text] [Related]
49. The BLM helicase contributes to telomere maintenance through processing of late-replicating intermediate structures.
Barefield C; Karlseder J
Nucleic Acids Res; 2012 Aug; 40(15):7358-67. PubMed ID: 22576367
[TBL] [Abstract][Full Text] [Related]
50. TRF2 recruits the Werner syndrome (WRN) exonuclease for processing of telomeric DNA.
Machwe A; Xiao L; Orren DK
Oncogene; 2004 Jan; 23(1):149-56. PubMed ID: 14712220
[TBL] [Abstract][Full Text] [Related]
51. Geminin overexpression prevents the completion of topoisomerase IIα chromosome decatenation, leading to aneuploidy in human mammary epithelial cells.
Gardner L; Malik R; Shimizu Y; Mullins N; ElShamy WM
Breast Cancer Res; 2011 May; 13(3):R53. PubMed ID: 21595939
[TBL] [Abstract][Full Text] [Related]
52. Topoisomerase II inhibition suppresses the proliferation of telomerase-negative cancers.
Hsieh MH; Tsai CH; Lin CC; Li TK; Hung TW; Chang LT; Hsin LW; Teng SC
Cell Mol Life Sci; 2015 May; 72(9):1825-37. PubMed ID: 25430478
[TBL] [Abstract][Full Text] [Related]
53. Break-induced replication promotes fragile telomere formation.
Yang Z; Takai KK; Lovejoy CA; de Lange T
Genes Dev; 2020 Oct; 34(19-20):1392-1405. PubMed ID: 32883681
[TBL] [Abstract][Full Text] [Related]
54. Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference.
Jiang WQ; Zhong ZH; Henson JD; Reddel RR
Oncogene; 2007 Jul; 26(32):4635-47. PubMed ID: 17297460
[TBL] [Abstract][Full Text] [Related]
55. BLM and RMI1 alleviate RPA inhibition of TopoIIIα decatenase activity.
Yang J; Bachrati CZ; Hickson ID; Brown GW
PLoS One; 2012; 7(7):e41208. PubMed ID: 22911760
[TBL] [Abstract][Full Text] [Related]
56. Telomeric protein TRF2 protects Holliday junctions with telomeric arms from displacement by the Werner syndrome helicase.
Nora GJ; Buncher NA; Opresko PL
Nucleic Acids Res; 2010 Jul; 38(12):3984-98. PubMed ID: 20215438
[TBL] [Abstract][Full Text] [Related]
57. Control of human telomere length by TRF1 and TRF2.
Smogorzewska A; van Steensel B; Bianchi A; Oelmann S; Schaefer MR; Schnapp G; de Lange T
Mol Cell Biol; 2000 Mar; 20(5):1659-68. PubMed ID: 10669743
[TBL] [Abstract][Full Text] [Related]
58. Lack of TRF2 in ALT cells causes PML-dependent p53 activation and loss of telomeric DNA.
Stagno D'Alcontres M; Mendez-Bermudez A; Foxon JL; Royle NJ; Salomoni P
J Cell Biol; 2007 Dec; 179(5):855-67. PubMed ID: 18056407
[TBL] [Abstract][Full Text] [Related]
59. Super-telomeres in transformed human fibroblasts.
Chiodi I; Belgiovine C; Zongaro S; Ricotti R; Horard B; Lossani A; Focher F; Gilson E; Giulotto E; Mondello C
Biochim Biophys Acta; 2013 Aug; 1833(8):1885-93. PubMed ID: 23570868
[TBL] [Abstract][Full Text] [Related]
60. Telomere repeat binding factors TRF1, TRF2, and hRAP1 modulate replication of Epstein-Barr virus OriP.
Deng Z; Atanasiu C; Burg JS; Broccoli D; Lieberman PM
J Virol; 2003 Nov; 77(22):11992-2001. PubMed ID: 14581536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
